Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress
Go back to Amgen And Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 At The European Society For Medical Oncology 2017 Congress| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 344.72 +7.12 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $337.60 | 52 Week High | $176.85 | |||
| Open | $337.65 | 52 Week Low | $133.64 | |||
| Day High | $345.11 | P/E | 51.92 | |||
| Day Low | $337.60 | EPS | $6.64 | |||
| Volume | 2,520,731 | |||||
| DIAGEO PLC (NYSE: DEO) | Delayed: 79.59 -0.86 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.45 | 52 Week High | $117.95 | |||
| Open | $79.68 | 52 Week Low | $99.46 | |||
| Day High | $80.62 | P/E | N/A | |||
| Day Low | $79.39 | EPS | $0.00 | |||
| Volume | 1,326,694 | |||||
| (AMEX: DGE) | Delayed: 0.00 -440.99 (100%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $440.99 | 52 Week High | $ | |||
| Open | $440.99 | 52 Week Low | $ | |||
| Day High | $440.99 | P/E | N/A | |||
| Day Low | $440.99 | EPS | $ | |||
| Volume | 0 | |||||
